Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

Fixed once-daily low doses of amlodipine 5mg and candesartan cilexetil 8mg were compared during 8–12 weeks of treatment. [8, 9, 10] There have also been a number of uptitration studies including ...

The Food and Drug Administration (FDA) has approved Widaplik ™ (telmisartan, amlodipine and indapamide), a single pill combination therapy, for the treatment of hypertension, including as ...

London, UK, Boston, MA, 9 June 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing unmet needs in cardiometabolic disease, today announces that the US Food and ...

The C-reactive protein level was 42.7 mg per deciliter (reference range, <3.0), and the erythrocyte sedimentation rate was 42 mm per hour (reference range, <20).

With the debut of the IM6, this will be the brand's first car in the UK, but with an MG badge. Diving into the details, the IM6 comes in three versions: Premium, Platinum, and Performance.